We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+74.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.09B
Cap. Flow
-$3.1M
Cap. Flow %
-0.07%
Top 10 Hldgs %
49.45%
Holding
523
New
34
Increased
205
Reduced
238
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$149M
2
AMD icon
Advanced Micro Devices
AMD
+$114M
3
ASML icon
ASML
ASML
+$83.3M
4
INTC icon
Intel
INTC
+$69.9M
5
KLAC icon
KLA
KLAC
+$61.9M

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$172M
2
AXTI icon
AXT Inc
AXTI
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.9M
4
GLW icon
Corning
GLW
+$87.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$79.8M

Sector Composition

Rank Sector Weight
1 Technology 66.9%
2 Consumer Discretionary 12.6%
3 Communication Services 5.91%
4 Miscellaneous 3.42%
5 Healthcare 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
276
Roivant Sciences
ROIV
$25.2B
$485K 0.01%
13,700
-5,468
-29% -$162K
FITB
277
Fifth Third Bancorp
FITB
$49.8B
$480K 0.01%
+8,515
New +$432K
RARE icon
278
Ultragenyx Pharmaceutical
RARE
$1.51B
$479K 0.01%
14,334
-6,462
-31% -$161K
PTGX icon
279
Protagonist Therapeutics
PTGX
$9.43B
$477K 0.01%
3,891
-2,142
-36% -$224K
VRT icon
280
Vertiv
VRT
$108B
$476K 0.01%
1,422
-9,626
-87% -$3.05M
ARWR icon
281
Arrowhead Research
ARWR
$12.2B
$476K 0.01%
5,841
-4,159
-42% -$307K
TVTX icon
282
Travere Therapeutics
TVTX
$6.15B
$473K 0.01%
8,328
-10,834
-57% -$480K
AKAM icon
283
Akamai
AKAM
$15.1B
$472K 0.01%
3,995
+148
+4% +$18.4K
PLD icon
284
Prologis
PLD
$131B
$471K 0.01%
3,478
+60
+2% +$8.51K
COP icon
285
ConocoPhillips
COP
$161B
$471K 0.01%
4,531
-54
-1% -$6.4K
MDGL icon
286
Madrigal Pharmaceuticals
MDGL
$12.5B
$469K 0.01%
873
-474
-35% -$243K
PH icon
287
Parker-Hannifin
PH
$121B
$467K 0.01%
477
+10
+2% +$9.16K
INSM icon
288
Insmed
INSM
$27.6B
$466K 0.01%
4,375
-6,641
-60% -$804K
ALKS icon
289
Alkermes
ALKS
$7.73B
$465K 0.01%
8,879
-12,041
-58% -$470K
LOW icon
290
Lowe's Companies
LOW
$115B
$462K 0.01%
2,097
+46
+2% +$10.4K
RLAY icon
291
Relay Therapeutics
RLAY
$4.17B
$461K 0.01%
24,645
+5,712
+30% +$82.9K
SYRE icon
292
Spyre Therapeutics
SYRE
$7.85B
$460K 0.01%
5,184
-1,972
-28% -$144K
PTCT icon
293
PTC Therapeutics
PTCT
$5.78B
$458K 0.01%
5,616
-3,247
-37% -$234K
HALO icon
294
Halozyme
HALO
$12.5B
$455K 0.01%
5,810
-2,933
-34% -$200K
PGR icon
295
Progressive
PGR
$127B
$453K 0.01%
2,074
-80
-4% -$16.1K
BEAM icon
296
Beam Therapeutics
BEAM
$3.06B
$453K 0.01%
13,199
-8,541
-39% -$258K
BBIO icon
297
BridgeBio Pharma
BBIO
$14.6B
$452K 0.01%
6,070
-2,092
-26% -$147K
CRSP icon
298
CRISPR Therapeutics
CRSP
$5.39B
$449K 0.01%
8,239
-3,372
-29% -$178K
IBRX icon
299
ImmunityBio
IBRX
$8.56B
$447K 0.01%
51,072
-19,149
-27% -$145K
BDX icon
300
Becton Dickinson
BDX
$50.3B
$446K 0.01%
2,948
+5
+0.2% +$748
10 11
12
13 14

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, E Fund Management held 523 positions worth $4.46B, up 32% from $3.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

E Fund Management's Q2 2026 filing shows 34 new, 205 increased, 238 reduced and 35 closed positions. Its largest new stake was Astera Labs: 196,877 shares worth $95.1M. The largest sale was Lumentum, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q2 2026 buy was Astera Labs: 196,877 shares worth $95.1M.
  • E Fund Management added most to Lam Research in Q2 2026, an estimated $149M increase.
  • E Fund Management's biggest Q2 2026 reduction was Lumentum, cutting an estimated $172M.
  • E Fund Management fully exited SPDR Gold MiniShares Trust in Q2 2026, selling an estimated $13.4M.
  • E Fund Management's ten largest holdings make up 49% of its $4.46B portfolio in Q2 2026.
  • E Fund Management opened 34 new positions and closed 35 in Q2 2026.
  • E Fund Management's portfolio value rose 32% quarter-over-quarter to $4.46B.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.